Werner Cautreels - Net Worth and Insider Trading
Werner Cautreels Net Worth
The estimated net worth of Werner Cautreels is at least $177,094 dollars as of 2024-09-20. Werner Cautreels is the President and CEO of Cartesian Therapeutics Inc and owns about 10,707 shares of Cartesian Therapeutics Inc (RNAC) stock worth over $177,094. Details can be seen in Werner Cautreels's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Werner Cautreels has not made any transactions after 2017-11-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Werner Cautreels
Werner Cautreels Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Werner Cautreels owns 3 companies in total, including Cartesian Therapeutics Inc (RNAC) , Seres Therapeutics Inc (MCRB) , and Arqule Inc (ARQL) .
Click here to see the complete history of Werner Cautreels’s form 4 insider trades.
Insider Ownership Summary of Werner Cautreels
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RNAC | Cartesian Therapeutics Inc | 2017-11-13 | director & 10 percent owner & President and CEO |
| MCRB | Seres Therapeutics Inc | 2015-06-25 | director |
| ARQL | Arqule Inc | 2005-05-18 | director |
Werner Cautreels Latest Holdings Summary
Werner Cautreels currently owns a total of 1 stock. Werner Cautreels owns 10,707 shares of Cartesian Therapeutics Inc (RNAC) as of November 13, 2017, with a value of $177,094.
Latest Holdings of Werner Cautreels
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics Inc | 2017-11-13 | 10,707 | 16.54 | 177,094 |
Holding Weightings of Werner Cautreels
Werner Cautreels Form 4 Trading Tracker
According to the SEC Form 4 filings, Werner Cautreels has made a total of 0 transactions in Cartesian Therapeutics Inc (RNAC) over the past 5 years. The most-recent trade in Cartesian Therapeutics Inc is the acquisition of 667 shares on November 13, 2017, which cost Werner Cautreels around $186,200.
Insider Trading History of Werner Cautreels
- 1
Werner Cautreels Trading Performance
GuruFocus tracks the stock performance after each of Werner Cautreels's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Werner Cautreels is -3.79%. GuruFocus also compares Werner Cautreels's trading performance to market benchmark return within the same time period. The performance of stocks bought by Werner Cautreels within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Werner Cautreels's insider trading performs compared to the benchmark.
Performance of Werner Cautreels
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.93 | | | | | |
| Relative Return to S&P 500(%) | 8.91 | | | | | |
Werner Cautreels Ownership Network
Werner Cautreels Owned Company Details
What does Cartesian Therapeutics Inc do?
Who are the key executives at Cartesian Therapeutics Inc?
Werner Cautreels is the director & 10 percent owner & President and CEO of Cartesian Therapeutics Inc. Other key executives at Cartesian Therapeutics Inc include Chief Medical Officer Peter G Traber , director & President & CEO Carsten Brunn , and Chief Scientific Officer Takashi Kei Kishimoto .
Cartesian Therapeutics Inc (RNAC) Insider Trades Summary
Over the past 18 months, Werner Cautreels made no insider transaction in Cartesian Therapeutics Inc (RNAC). Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 1,231,332 shares made by Timothy A Springer , a net purchase of 7,500 shares made by Timothy C Barabe , and a net sale of 2,932 shares made by Carsten Brunn .
In summary, during the past 3 months, insiders sold 0 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 15,516 shares, with a net purchase of 15,516 shares. During the past 18 months, 121 shares of Cartesian Therapeutics Inc (RNAC) were sold and 56,293 shares were bought by its insiders, resulting in a net purchase of 56,172 shares.
Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cartesian Therapeutics Inc Insider Transactions
Werner Cautreels Mailing Address
Above is the net worth, insider trading, and ownership report for Werner Cautreels. You might contact Werner Cautreels via mailing address: 812 Colony Rd, Bryn Mawr Pa 19010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
